APOL1 and pneumocystosis: There is some evidence that variant APOL1 confers partial protection against multiple fungal pathogens, with nonsignificant protective trends for Pneumocystis carinii pneumonia and esophageal candidiasis and a significant protective association with Cryptococcal meningitis (P = 0.03).